MedTrace Logo

Incorporation of Vitamin K Into Uremic Lipoproteins

NCT05360342 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-05-04

No results posted yet for this study

Summary

Chronic kidney disease (CKD) patients have an increased cardiovascular risk with corresponding cardiovascular calcifications. CKD patients exhibit a functional vitamin K deficiency. Calcification can be prevented by vitamin K intake. The aim of this study is to investigate the cause for the vitamin K deficiency beyond a diminished dietary vitamin K uptake.

Conditions

  • Vitamin K Deficiency

Interventions

DRUG

Vitamin K supplement

Single dose of vitamin K supplement

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Jürgen Floege, MD · RWTH Aachen University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-31
Primary Completion
2021-07-15
Completion
2021-09-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05360342 on ClinicalTrials.gov